Filing Flows › Omada Health (OMDA) › R&D spending
Omada Health (OMDA) R&D spending by quarter
Omada Health's R&D spending was $15.3M in Q3 2026 (third quarter 2026), +4% from Q2 2026. Over the last 6 quarters it ranged from $10.0M (Q2 2025) to $15.3M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $15.3M | +4% | +48% |
| Q2 2026 | $14.6M | +15% | +46% |
| Q1 2026 | $12.7M | +10% | — |
| Q4 2025 | $11.6M | +12% | — |
| Q3 2025 | $10.3M | +3% | — |
| Q2 2025 | $10.0M | — | — |
Q3 2026 at a glance
Omada Health, Q3 2026: revenue $91.3M (+34% year over year), operating margin 5.3%, net earnings $6.6M, operating cash flow $15.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Omada Health's R&D spending?
Omada Health's R&D spending was $15.3M in Q3 2026 (third quarter 2026), +4% from Q2 2026.
How has Omada Health's R&D spending changed?
Over the last 6 quarters it ranged from $10.0M (Q2 2025) to $15.3M (Q3 2026).